Lupin to buy US-based Gavis Pharmaceuticals for $880 mn

Drug major Lupin Thursday said it is acquiring US-based Gavis for USD 880 million (over Rs 5,610 crore) to consolidate presence in the world's largest pharmaceuticals market.

Sun settles Angiomax litigation with The Medicines Company

Drug major Sun Pharmaceutical Industries has entered into a settlement pact with US-based The Medicines Company for settling the lawsuit filed against it by the later for generic Angiomax.

Cipla to launch generic Hepatitis C drug 'Hepcvir' in India

Drug major Cipla on Wednesday announced the launch of generic drug Sofosbuvir for treating chronic Hepatitis C under the brand name 'Hepcvir', in India.

Aurobindo Pharma to acquire Activis' ops in 7 European nations

Generic drug maker Aurobindo Pharma has signed a binding offer agreement to acquire commercial operations of Dublin-based Actavis plc in seven Western European countries.

Wockhardt shares fall after FDA ban on another plant

A second plant operated by generic drugmaker Wockhardt Ltd was hit by the U.S. Food and Drug Administration with an "import alert", effectively a ban, clouding the company's earnings outlook and sending its shares down as much as 13.5 percent.

Indian companies in FDA`s first list for generic Aciphex tablets

Indian firms including Dr Reddy`s, Lupin and Torrent Pharma have received nod from the US health regulator to market the first generic version of Aciphex, used to treat gastroesophageal reflux disease (GERD).

Dr Reddy's to launch anti-blood clot drug in Canada

Country's largest drug maker Dr Reddy's Laboratories is set to take its complex generic drug Fondaparinux sodium injection to Canada and two other emerging markets.

Sun Pharma gets USFDA nod for generic duodenal ulcer capsules

Drug firm Sun Pharmaceutical Industries today said it has received final approval from the US health regulator for its generic Lansoprazole delayed- release capsules used for treating duodenal ulcer.

Dr Reddy’s Labs, Fujifilm call off proposed generic drug JV

Though the Memorandum of Understanding for generic drugs has been cancelled, both the companies will explore partnerships in other related areas, said a statement issued by DRL.

Ranbaxy stops production of its generic Lipitor: USFDA

Ranbaxy Laboratories has stopped production of its generic version of cholesterol lowering drug Lipitor.

Lupin launches generic cholesterol lowering drug in US

Drug-maker Lupin Tuesday said its subsidiary Lupin Pharmaceuticals Inc has launched cholesterol lowering drug Fenofibrate tablets in 48mg and 145mg strengths in the United States.

Cipla slashes cancer drug prices by up to 64%

Giving some relief to cancer patients, pharma major Cipla today slashed prices of its three generic cancer drugs by up to 64 per cent.

Lupin gets USFDA approval for generic Lexapro tablets

Drug firm Lupin Ltd today said it has received American health regulator`s approval to market Escitalopram tablets, used in treating depressive disorders, in the US market.

Wockhardt gets USFDA nod for generic Parkinson’s drug

Wockhardt on Tuesday said that it has received US FDA approval for marketing a generic version of extended—release tablets containing Ropinirole hydrochloride.

Ranbaxy launches generic diabetes drug in US

Ranbaxy Laboratories today said it has launched generic pioglitazone hydrochloride tablets used for treating diabetes in the American market.

Wockhardt to launch generic version of Plavix

Wockhardt has received final approval from the United States Food & Drug Administration for marketing tablets of Clopidogrel bisulfate.

US pushing India to hike cancer drug price

Obama administration is pressurising India and other countries to impose higher prices even for lifesaver cancer drugs.

Rs 27,000 crore project for free medicines to start this year

In an ambitious project, government proposes to provide free medicines to millions of people through a Rs 27,000 crore joint initiative of the Centre and states within this year.

Rs 27,000 crore project for free medicines to start this year

In an ambitious project, government proposes to provide free medicines to millions of people through a Rs 27,000 crore joint initiative of the Centre and states within this year.

Pfizer names Alembic, Breckenridge as co-defendants in lawsuit

Alembic Pharma today said Pfizer has filed a lawsuit against it and US firm Breckenridge Pharma for their move to market generic tablets for treating depression.